Cannabis Evidence Series, February 2, 2017
Cannabis Evidence Series An Evidence Synthesis The Health Technology Assessment Unit, University of Calgary February 2, 2017 Cannabis Evidence Series February 2, 2017 Acknowledgements This report is authored by Laura E. Dowsett, Ally Memedovich, Hannah Holitzki, Laura Sevick, Sarah Ghali, Tamara McCarron, Stephanie Coward, Kelsey Brooks, Kai Lukowiak, Dolly Han, Vishva Danthurebandara, Diane Lorenzetti, Rebecca Haines-Saah, Tom Noseworthy, Eldon Spackman, and Fiona Clement on behalf of the HTA Unit at the University of Calgary. The authors declare no conflict of interests. This report was supported by a financial contribution from Alberta Health through the Alberta Health Technologies Decision Process, the Alberta model for health technology assessment (HTA) and policy analysis. The views expressed herein do not necessarily represent the official policy of Alberta Health. © 2016 Government of Alberta 2 Cannabis Evidence Series February 2, 2017 Issue Cannabis is the most widely used illicit drug in Canada; however, it is illegal to possess, produce or sell it 1. In 2015, the Liberal government of Canada formed a majority government and announced their plan to legalize cannabis. In June of 2016, a nine-member federal task force on cannabis was announced. The task force, chaired by Anne McLellan, includes representation from Quebec, British Columbia, Newfoundland and Labrador, Ontario, and Saskatchewan 2. Guided by this task force, cannabis legislation is expected to be introduced in 2017. Objective To inform Alberta’s response to the federal decision to legalize cannabis, the University of Calgary Health Technology Assessment (HTA) Unit is developing a series of evidence syntheses to support policy development by the Government of Alberta.
[Show full text]